Skip to main content
AVTR
NYSE Industrial Applications And Services

Avantor Reports Significant Full-Year Net Loss and Goodwill Impairment, Announces Segment Realignment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
8
Price
$9.87
Mkt Cap
$7.609B
52W Low
$10.62
52W High
$19.525
52W Position info
7.1% below low
Off High info
49% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

AVTR is trading near its 52-week low of $10.62 (7.1% below the low) on elevated volume (2.6× avg).

Summary

Avantor reported a substantial full-year net loss of $530 million, including a $785 million goodwill impairment, alongside declining organic sales and a strategic business segment realignment.


Key Events · Earnings and Guidance · AVTR

  • Significant Full-Year Net Loss

    Avantor reported a net loss of $530 million for 2025, a sharp decline from a net income of $712 million in 2024.

  • Major Goodwill Impairment

    The reported net loss was primarily due to a $785 million goodwill impairment charge related to its Distribution reporting unit.

  • Organic Sales Decline

    The company experienced a 2.8% organic sales decline for the full year 2025 and a 4.1% organic decline in Q4 2025.

  • Business Segment Realignment

    Effective Q1 2026, Avantor will realign its operations into two new reportable segments: VWR Distribution & Services and Bioscience & Medtech Products, providing recast historical data for investor understanding.


Analysis · AVTR · Industrial Applications And Services

Avantor, Inc. reported a substantial net loss for the full year 2025, primarily driven by a significant $785 million goodwill impairment charge. The company also experienced organic sales declines in both the fourth quarter and full year, indicating ongoing operational challenges. In response to these issues, Avantor has initiated a "Revival program" and is realigning its business into two new segments, signaling a strategic shift to improve future performance. The stock is currently trading below its 52-week low, reflecting heightened investor concerns over the company's financial health and outlook.

At the time of this filing, AVTR was trading at $9.87 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $10.62 to $19.53. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AVTR - Latest Insights

AVTR
Jul 29, 2026, 6:13 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.40
Real-time Price: $13.09 info
Change: -$0.3123 (-2%) info
Market Cap: $8.48B info
AVTR
Jul 29, 2026, 6:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.90
Real-time Price: $13.09 info
Change: +$0.1905 (+1%) info
Market Cap: $8.48B info
AVTR
Apr 29, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.34
Real-time Price: $13.09 info
Change: +$4.75 (+57%) info
Market Cap: $8.48B info
AVTR
Apr 29, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $13.09 info
Change: +$4.59 (+54%) info
Market Cap: $8.48B info
AVTR
Apr 29, 2026, 6:05 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.91
Real-time Price: $13.09 info
Change: +$5.18 (+65%) info
Market Cap: $8.48B info